| Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants IMpact-RSV Study Group Pediatrics 102 (3), 531-537, 1998 | 2096 | 1998 |
| Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America SK Gupta, JA Eustace, JA Winston, II Boydstun, TS Ahuja, RA Rodriguez, ... Clinical Infectious Diseases 40 (11), 1559-1585, 2005 | 795 | 2005 |
| Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel SM Graham, T Ahmed, F Amanullah, R Browning, V Cardenas, ... Journal of Infectious Diseases 205 (suppl_2), S199-S208, 2012 | 404 | 2012 |
| Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci A Tomasz, S Nachman, H Leaf Antimicrobial agents and chemotherapy 35 (1), 124-129, 1991 | 375 | 1991 |
| Incidence of opportunistic and other infections in HIV-infected children in the HAART era P Gona, RB Van Dyke, PL Williams, WM Dankner, MC Chernoff, ... Jama 296 (3), 292-300, 2006 | 330 | 2006 |
| Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection RB Van Dyke, S Lee, GM Johnson, A Wiznia, K Mohan, K Stanley, ... Pediatrics 109 (4), e61-e61, 2002 | 309 | 2002 |
| Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid ME Villarino, NA Scott, SE Weis, M Weiner, MB Conde, B Jones, ... JAMA pediatrics 169 (3), 247-255, 2015 | 240 | 2015 |
| Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission. G Fang, H Burger, R Grimson, P Tropper, S Nachman, D Mayers, ... Proceedings of the National Academy of Sciences 92 (26), 12100-12104, 1995 | 239 | 1995 |
| A behavioral and cognitive profile of clinically stable HIV-infected children ML Nozyce, SS Lee, A Wiznia, S Nachman, LM Mofenson, ME Smith, ... Pediatrics 117 (3), 763-770, 2006 | 231 | 2006 |
| Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022 J Hitti, LM Frenkel, AM Stek, SA Nachman, D Baker, A Gonzalez-Garcia, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 36 (3), 772-776, 2004 | 215 | 2004 |
| Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children SA Madhi, S Nachman, A Violari, S Kim, MF Cotton, R Bobat, ... New England Journal of Medicine 365 (1), 21-31, 2011 | 199 | 2011 |
| Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth DM Fernandes, CR Oliveira, S Guerguis, R Eisenberg, J Choi, M Kim, ... The Journal of pediatrics 230, 23-31. e10, 2021 | 189 | 2021 |
| Nucleoside analogs plus ritonavir in stable antiretroviral therapy–experienced HIV-infected children: A randomized controlled trial SA Nachman, K Stanley, R Yogev, S Pelton, A Wiznia, S Lee, L Mofenson, ... Jama 283 (4), 492-498, 2000 | 170 | 2000 |
| Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection DM Gaughan, MD Hughes, JM Oleske, K Malee, CA Gore, S Nachman, ... Pediatrics 113 (6), e544-e551, 2004 | 150 | 2004 |
| Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children RJ Jeremy, S Kim, M Nozyce, S Nachman, K McIntosh, SI Pelton, R Yogev, ... Pediatrics 115 (2), 380-387, 2005 | 147 | 2005 |
| CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children A Saitoh, E Sarles, E Capparelli, F Aweeka, A Kovacs, SK Burchett, ... Aids 21 (16), 2191-2199, 2007 | 143 | 2007 |
| Cryptococcosis in children with AIDS J Abadi, S Nachman, AB Kressel, L Pirofski Clinical infectious diseases 28 (2), 309-313, 1999 | 134 | 1999 |
| Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy SA Nachman, JC Lindsey, J Moye, KE Stanley, GM Johnson, PA Krogstad, ... The Pediatric infectious disease journal 24 (4), 352-357, 2005 | 132 | 2005 |
| Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci D Jabes, S Nachman, A Tomasz Journal of Infectious Diseases 159 (1), 16-25, 1989 | 131 | 1989 |
| Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. B Weiser, S Nachman, P Tropper, KH Viscosi, R Grimson, G Baxter, ... Proceedings of the National Academy of Sciences 91 (17), 8037-8041, 1994 | 129 | 1994 |
